DEPRESSION AND GRIEF MAPS: 1A | 1B | 2 | 3 | 4 | 5
depr1Aa
SECTIONS: 1 | 2 | 8 | 23
DEPRESSION AND GRIEF MAPS: 1A | 1B | 2 | 3 | 4 | 5
depr1B
SECTIONS: 3 | 4 | 8 | 9 | 10 | 11 | 12 | 13 | 14
DEPRESSION AND GRIEF MAPS: 1A | 1B | 2 | 3 | 4 | 5
depr2a
SECTIONS: 5 | 8 | 16 | 19 | 21 | 22 | 24 | 25 | 39 | 44 | 46 | 47 | 48
DEPRESSION AND GRIEF MAPS: 1A | 1B | 2 | 3 | 4 | 5
depr3
SECTIONS: 8 | 28 | 29 | 30 | 32 | 33 | 34 | 35 | 36 | 37 | 39
DEPRESSION AND GRIEF MAPS: 1A | 1B | 2 | 3 | 4 | 5
depr4
SECTIONS: 8 | 31 | 38 | 39 | 40 | 41 | 42 | 43 | 45 | 46 | 47 | 49
DEPRESSION AND GRIEF MAPS: 1A | 1B | 2 | 3 | 4 | 5
depr5
SECTIONS: 6 | 7 | 8 | 46 | 50
31. ADJUNCTIVE CARE DECISION

    This decision follows after and from your decision regarding the primary form of treatment, Section 30 on Map 3. It appears on the top of Map 4.

Once the form of primary treatment has been decided upon, you need to consider what, if any, additional care can be helpful to the patient.

It may include making life changes, such as

  • developing new connections with family or friends [ Section 41 ]
  • an exercise program [ Section 40 ]
  • change of diet
  • meaningful activity

It may also include biological treatments such as

31a. Support Groups

Depressed people commonly feel very alone and lonely. They may also avoid others, thus creating or increasing their sense of being different, unworthy, strange, rejected, etc.

A group of others who have similar issues can lessen the sense of uniqueness and alienation. Group members can support one another in many ways, through understanding, outside contact and help, social events, etc.

31b. New Connections with Family and Friends

31c. Exercise

31d. Change of Diet

31e. Meaningful Activity

31f. Medication

We have some ambivalence about whether medication is adjunctive care or an integral part of primary treatment, because the answer depends on whether there appears to be a biological component to the patient’s depression, along with the patient’s level of depression and ability to cope with it.

Potential advantages of medicating

  • reduce symptomatology
  • help the patient feel better
  • help the patient cope more effectively with everyday life

Potential advantages of not medicating

  • ―use the patient’s distress as a motivator explore
  • ―interpersonal and intrapsychic sources of the distress

Risks of medicating could include

  • giving a nonverbal message that the patient’s issues are primarily biological or that the patient is too disturbed to be helped psychotherapeutically.
  • supporting the idea that therapeutic work isn’t necessary

Risk of not medicating might include

  • ―patient’s inference that s/he is not being taken seriously
  • ―patient’s actually being so depressed that s/he can’t manage his/her life effectively, and gets worse.

SIGNS OF A BIOLOGICAL COMPONENT THAT ANTIDEPRESSANTS COULD HELP

  • Fatigue
  • Sleep disturbance, especially:

―several awakenings each night
―early morning awakenings, difficulty returning to sleep
―excessive sleeping or lack of sleep

  • Decreased sex drive
  • Consistent mood changes throughout the day – usually feeling better as the day progresses
  • Extreme inability to feel pleasure
  • Forgetfulness
  • Difficulty concentrating

OTHER USES OF MEDICATION

  • Anxiolytics to manage anxiety that has precipitated the depressive episode
  • Hypnotics when sleep loss is a significant factor in the patient’s mood, ability to concentrate, etc.
  • Medical treatment of other biological disorders that are contributing to the patient’s mood

Additional Issues That Should be Addressed

  • Whether to refer to a psychiatrist or internist
  • What to tell the psychiatrist or internist
  • What to tell the patient about medication
  • How to deal with any medication issues that arise.

These are discussed in Section 39.

31g. Shock Treatment

Electroshock treatment is more expensive and less available than medication. However, in some cases it may be safer, in its current form, than medication. It may in fact be the treatment of choice for the elderly, pregnant women, and patients with dementia or serious illness.

The primary risk, memory loss, is usually temporary and not disabling.

There is a relatively high probability of relapse following shock treatment; however, it can be reduced by maintenance treatment or psychotherapy.